時代環球集團(02310.HK):Great Match場內出售50萬股 恢復最低公眾持股量
格隆匯9月5日丨時代環球集團(02310.HK)公佈,公司獲悉,於2022年9月2日,Great Match已藉公開市場出售方式,向獨立第三方出售合共50萬股股份,佔已發行股份總數約0.05%。據董事經作出一切合理查詢後所深知、全悉及確信,買方並非公司核心關連人士(定義見上市規則),且為公眾人士(定義見上市規則第8.24條)。
於Great Match出售後,公眾人士合共持有273,221,181股股份,佔已發行股份約25%。因此,公司已恢復最低公眾持股量,且公司符合上市規則第8.08(1)(a)條之規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.